Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Michielan, Andrea ^a   D'Incà, Renata ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CELL ADHESION MOLECULE; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; ZINC; TUMOR NECROSIS FACTOR;

CLINICAL EVALUATION; CLINICAL PRACTICE; CONFOCAL LASER MICROSCOPY; CROHN DISEASE; ENTERITIS; HUMAN; IMMUNE RESPONSE; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS; ANTAGONISTS AND INHIBITORS; INFLAMMATORY BOWEL DISEASES; INTESTINE; METABOLISM; PERMEABILITY;

HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; PERMEABILITY; PROBIOTICS; TUMOR NECROSIS FACTOR-ALPHA; ZINC;

EID: 84947461191     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/628157     Document Type: Review

References (146)

1. D. C. Savage, "Microbial ecology of the gastrointestinal tract, " Annual Review of Microbiology, vol. 31, pp. 107-133, 1977.
2. R. Orel and T. K. Trop, "Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease, " World Journal of Gastroenterology, vol. 20, no. 33, pp. 11505-11524, 2014.
3. J. Stephani, K. Radulovic, and J. H. Niess, "Gut microbiota, probiotics and inflammatory bowel disease, " Archivum Immunologiae et Therapiae Experimentalis, vol. 59, no. 3, pp. 161-177, 2011.
4. F. Tsai andW. J. Coyle, "The microbiome and obesity: is obesity linked to our gut flora?" Current Gastroenterology Reports, vol. 11, no. 4, pp. 307-313, 2009.
5. T. J. Borody, S. Paramsothy, and G. Agrawal, "Fecalmicrobiota transplantation: indications, methods, evidence, and future directions, " Current Gastroenterology Reports, vol. 15, no. 8, article 337, 2013.
6. G. Escobedo, E. López-Ortiz, and I. Torres-Castro, "Gut microbiota as a key player in triggering obesity, systemic inflammation and insulin resistance, " Revista de Investigación Clínica, vol. 66, no. 5, pp. 450-459, 2014.
7. D. Festi, R. Schiumerini, L. H. Eusebi, G. Marasco, M. Taddia, and A. Colecchia, "Gut microbiota and metabolic syndrome, " World Journal of Gastroenterology, vol. 20, no. 43, pp. 16079-16094, 2014.
8. J. H. Cummings, J. M. Antoine, F. Azpiroz et al. , "PASSCLAIM 1-gut health and immunity, " European Journal of Nutrition, vol. 43, supplement 2, pp. ii118-ii173, 2004.
9. S. C. Bischoff, G. Barbara, W. Buurman et al. , "Intestinal permeability-A new target for disease prevention and therapy, " BMC Gastroenterology, vol. 14, article 189, 2014.
10. L. V. Hooper, D. R. Littman, andA. J. Macpherson, "Interactions between the microbiota and the immune system, " Science, vol. 336, no. 6086, pp. 1268-1273, 2012.
11. C. L. Maynard, C. O. Elson, R. D. Hatton, and C. T. Weaver, "Reciprocal interactions of the intestinal microbiota and immune system, " Nature, vol. 489, no. 7415, pp. 231-241, 2012.
12. J. E. Fishman, G. Levy, V. Alli, X. Zheng, D. J. Mole, and E. A. Deitch, "The intestinal mucus layer is a critical component of the gut barrier that is damaged during acute pancreatitis, " Shock, vol. 42, no. 3, pp. 264-70, 2014.
13. G. M. Swank and E. A. Deitch, "Role of the gut in multiple organ failure: bacterial translocation and permeability changes, " World Journal of Surgery, vol. 20, no. 4, pp. 411-417, 1996.
14. J. P. M. Derikx, D. A. van Waardenburg, G. Thuijls et al. , "New insight in loss of gut barrier duringmajor non-Abdominal surgery, " PLoS ONE, vol. 3, no. 12, Article IDe3954, 2008.
15. A. Z. Al-Bahrani, A. Darwish, N. Hamza et al. , "Gut barrier dysfunction in critically ill surgical patients with abdominal compartment syndrome, " Pancreas, vol. 39, no. 7, pp. 1064-1069, 2010.
16. J. J. deHaan, T. Lubbers, J. P. Derikx et al. , "Rapid development of intestinal cell damage following severe trauma: a prospective observational cohort study, " Critical Care, vol. 13, no. 3, article R86, 2009.
17. M. Camilleri, K. Lasch, and W. Zhou, "Irritable bowel syndrome: methods, mechanisms, and pathophysiology: the confluence of increased permeability, inflammation, and pain in irritable bowel syndrome, " American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 303, no. 7, pp. G775-G785, 2012.
18. C. Martínez, B. Lobo, M. Pigrau et al. , "Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier, " Gut, vol. 62, no. 8, pp. 1160-1168, 2013.
19. Z. Mujagic, S. Ludidi, D. Keszthelyi et al. , "Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to confounders, " Alimentary Pharmacology andTherapeutics, vol. 40, no. 3, pp. 288-297, 2014.
20. E. Scarpellini, M. Lupo, C. Iegri, A. Gasbarrini, A. De Santis, and J. Tack, "Intestinal permeability in non-Alcoholic fatty LIVER disease: the gut-liver axis, "Reviews onRecent Clinical Trials, vol. 9, no. 3, pp. 141-147, 2014.
21. K. Ray, "NAFLD: leaky guts: intestinal permeability andNASH, " Nature Reviews Gastroenterology and Hepatology, vol. 12, no. 3, article 123, 2015.
22. M. Coskun, "Intestinal epithelium in inflammatory bowel disease, " Frontiers in Medicine, vol. 1, article 24, 2014.
23. J. Mankertz and J.-D. Schulzke, "Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications, " Current Opinion in Gastroenterology, vol. 23, no. 4, pp. 379-383, 2007.
24. L. Antoni, S. Nuding, J. Wehkamp, and E. F. Stange, "Intestinal barrier in inflammatory bowel disease, " World Journal of Gastroenterology, vol. 20, no. 5, pp. 1165-1179, 2014.
25. S. Jager, E. F. Stange, and J. Wehkamp, "Inflammatory bowel disease: an impaired barrier disease, " Langenbeck's Archives of Surgery, vol. 398, no. 1, pp. 1-12, 2013.
26. K. R. Groschwitz and S. P. Hogan, "Intestinal barrier function: molecular regulation and disease pathogenesis, " Journal of Allergy and Clinical Immunology, vol. 124, no. 1, pp. 3-22, 2009.
27. G. Roda, A. Sartini, E. Zambon et al. , "Intestinal epithelial cells in inflammatory bowel diseases, " World Journal of Gastroenterology, vol. 16, no. 34, pp. 4264-4271, 2010.
28. J. D. Söderholm, K. H. Peterson, G. Olaison et al. , "Epithelial permeability to proteins in the noninflamed ileum of Crohn's disease?" Gastroenterology, vol. 117, no. 1, pp. 65-72, 1999.
29. S. Y. Salim and J. D. Söderholm, "Importance of disrupted intestinal barrier in inflammatory bowel diseases, " Inflammatory Bowel Diseases, vol. 17, no. 1, pp. 362-381, 2011.
30. S. H. Lee, "Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases, " Intestinal Research, vol. 13, no. 1, pp. 11-18, 2015.
31. S. Zeissig, N. Bürgel, D. Günzel et al. , "Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease, " Gut, vol. 56, no. 1, pp. 61-72, 2007.
32. S. Vetrano, M. Rescigno, M. R. Cera et al. , "Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease, " Gastroenterology, vol. 135, no. 1, pp. 173-184, 2008.
33. K. L. Edelblum and J. R. Turner, "The tight junction in inflammatory disease: communication breakdown, " Current Opinion in Pharmacology, vol. 9, no. 6, pp. 715-720, 2009.
34. S. M. Krug, J. D. Schulzke, and M. Fromm, "Tight junction, selective permeability, and related diseases, " Seminars in Cell and Developmental Biology, vol. 36, pp. 166-176, 2014.
35. H. Tanaka, M. Takechi, H. Kiyonari, G. Shioi, A. Tamura, and S. Tsukita, "Intestinal deletion of Claudin-7 enhances paracellular organic solute flux and initiates colonic inflammation in mice, " Gut, vol. 64, no. 10, pp. 1529-1538, 2015.
36. H. Schmitz, M. Fromm, C. J. Bentzel et al. , "Tumor necrosis factor alpha (TNF) regulates the epithelial barrier in the human intestinal cell lineHT-29/B6, " Journal of Cell Science, vol. 112, part 1, pp. 137-146, 1999.
37. P. Suenaert, V. Bulteel, L. Lemmens et al. , "Anti-Tumor necrosis factor treatment restores the gut barrier in Crohn's disease, " American Journal of Gastroenterology, vol. 97, no. 8, pp. 2000-2004, 2002.
38. M. Marini, G. Bamias, J. Rivera-Nieves et al. , "TNF-Alpha neutralization ameliorates the severity ofmurine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8366-8371, 2003.
39. F. Heller, P. Florian, C. Bojarski et al. , "Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution, " Gastroenterology, vol. 129, no. 2, pp. 550-564, 2005.
40. L. Su, S. C. Nalle, L. Shen et al. , "TNFR2 activates mlckdependent tight junction dysregulation to cause apoptosismediated barrier loss and experimental colitis, " Gastroenterology, vol. 145, no. 2, pp. 407-415, 2013.
41. A. J. M. Watson and K. R. Hughes, "TNF-induced intestinal epithelial cell shedding: implications for intestinal barrier function, " Annals of the New York Academy of Sciences, vol. 1258, no. 1, pp. 1-8, 2012.
42. R. D. Pullan, G. A. O. Thomas, M. Rhodes et al. , "Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis, " Gut, vol. 35, no. 3, pp. 353-359, 1994.
43. M. Gersemann, J. Wehkamp, and E. F. Stange, "Innate immune dysfunction in inflammatory bowel disease, " Journal of Internal Medicine, vol. 271, no. 5, pp. 421-428, 2012.
44. S.-J. Chen, X.-W. Liu, J.-P. Liu, X.-Y. Yang, and F.-G. Lu, "Ulcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrier, " World Journal of Gastroenterology, vol. 20, no. 28, pp. 9468-9475, 2014.
45. A. Braun, I. Treede, D. Gotthardt et al. , "Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: a clue to pathogenesis, " Inflammatory Bowel Diseases, vol. 15, no. 11, pp. 1705-1720, 2009.
46. J. M. H. Larsson, H. Karlsson, J. G. Crespo et al. , "Altered Oglycosylation profile ofMUC2mucin occurs in active ulcerative colitis and is associated with increased inflammation, " Inflammatory Bowel Diseases, vol. 17, no. 11, pp. 2299-2307, 2011.
47. J. R. Clamp, G. Fraser, and A. E. Read, "Study of the carbohydrate content ofmucus glycoproteins from normal and diseased colons, " Clinical Science, vol. 61, no. 2, pp. 229-234, 1981.
48. A. H. Raouf, H. H. Tsai, N. Parker, J. Hoffman, R. J. Walker, and J. M. Rhodes, "Sulphation of colonic and rectalmucin in inflammatory bowel disease: reduced sulphation of rectal mucus in ulcerative colitis, " Clinical Science, vol. 83, no. 5, pp. 623-626, 1992.
49. C. A. Müller, I. B. Autenrieth, and A. Peschel, "Innate defenses of the intestinal epithelial barrier, " Cellular and Molecular Life Sciences, vol. 62, no. 12, pp. 1297-1307, 2005.
50. R. N. Cunliffe, F. R. A. J. Rose, J. Keyte, L. Abberley, W. C. Chan, and Y. R. Mahida, "Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease, " Gut, vol. 48, no. 2, pp. 176-185, 2001.
51. J. Wehkamp, J. Harder, M. Weichenthal et al. , "Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis, " Inflammatory Bowel Diseases, vol. 9, no. 4, pp. 215-223, 2003.
52. M. J. Koslowski, J. Beisner, E. F. Stange, and J. Wehkamp, "Innate antimicrobial host defense in small intestinal Crohn's disease, " International Journal ofMedicalMicrobiology, vol. 300, no. 1, pp. 34-40, 2010.
53. M. Gersemann, J. Wehkamp, K. Fellermann, and E. F. Stange, "Crohn's disease-defect in innate defence, " World Journal of Gastroenterology, vol. 14, no. 36, pp. 5499-5503, 2008.
54. C. W. Teshima, L. A. Dieleman, and J. B. Meddings, "Abnormal intestinal permeability in Crohn's disease pathogenesis, " Annals of theNew York Academy of Sciences, vol. 1258, no. 1, pp. 159-165, 2012.
55. M. Vivinus-Nebot, G. Frin-Mathy, H. Bzioueche et al. , "Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation, " Gut, vol. 63, no. 5, pp. 744-752, 2014.
56. B. Khor, A. Gardet, and R. J. Xavier, "Genetics and pathogenesis of inflammatory bowel disease, " Nature, vol. 474, no. 7351, pp. 307-317, 2011.
57. D. Hollander, C. M. Vadheim, E. Brettholz, G. M. Petersen, T. Delahunty, and J. I. Rotter, "Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor, " Annals of Internal Medicine, vol. 105, no. 6, pp. 883-885, 1986.
58. G. R. May, L. R. Sutherland, and J. B. Meddings, "Is small intestinal permeability really increased in relatives of patients with Crohn's disease?" Gastroenterology, vol. 104, no. 6, pp. 1627-1632, 1993.
59. P. Munkholm, E. Langholz, D. Hollander et al. , "Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives, " Gut, vol. 35, no. 1, pp. 68-72, 1994.
60. M. Peeters, B. Geypens, D. Claus et al. , "Clustering of increased small intestinal permeability in families with Crohn's disease, " Gastroenterology, vol. 113, no. 3, pp. 802-807, 1997.
61. R. K. Russell and J. Satsangi, "IBD: a family affair, " Best Practice and Research: Clinical Gastroenterology, vol. 18, no. 3, pp. 525-539, 2004.
62. W. Fries, M. C. Renda, M. A. Lo Presti et al. , "Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy, "The American Journal of Gastroenterology, vol. 100, no. 12, pp. 2730-2736, 2005.
63. R. D'Incà, V. Annese, V. Di Leo et al. , "Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease, "Alimentary Pharmacology andTherapeutics, vol. 23, no. 10, pp. 1455-1461, 2006.
64. S. Buhner, C. Buning, J. Genschel et al. , "Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?" Gut, vol. 55, no. 3, pp. 342-347, 2006.
65. D. Kevans, W. Turpin, K. Madsen et al. , "Determinants of intestinal permeability in healthy first-degree relatives of individuals with Crohn's disease, " Inflammatory Bowel Diseases, vol. 21, no. 4, pp. 879-887, 2015.
66. E. J. Irvine and J. K. Marshall, "Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk, " Gastroenterology, vol. 119, no. 6, pp. 1740-1744, 2000.
67. M. Chichlowski and L. P. Hale, "Bacterial-mucosal interactions in inflammatory bowel disease-An alliance gone bad, " The American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 295, no. 6, pp. G1139-G1149, 2008.
68. J.-P. Hugot, M. Chamaillard, H. Zouali et al. , "Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease, " Nature, vol. 411, no. 6837, pp. 599-603, 2001.
69. Y. Ogura, D. K. Bonen, N. Inohara et al. , "A frameshiftmutation in NOD2 associated with susceptibility to Crohn's disease, " Nature, vol. 411, no. 6837, pp. 603-606, 2001.
70. J. Hampe, A. Franke, P. Rosenstiel et al. , "A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1, " Nature Genetics, vol. 39, no. 2, pp. 207-211, 2007.
71. M. Parkes, J. C. Barrett, N. J. Prescott et al. , "Sequence variants in the autophagy gene IRGMandmultiple other replicating loci contribute to Crohn's disease susceptibility, " Nature Genetics, vol. 39, no. 7, pp. 830-832, 2007.
72. S. A. McCarroll, A. Huett, P. Kuballa et al. , "Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease, " Nature Genetics, vol. 40, no. 9, pp. 1107-1112, 2008.
73. T. Petnicki-Ocwieja, T. Hrncir, Y.-J. Liu et al. , "Nod2 is required for the regulation of commensal microbiota in the intestine, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 37, pp. 15813-15818, 2009.
74. P. K. Nighot, C. A. Hu, and T. Y. Ma, "Autophagy enhances intestinal epithelial tight junction barrier function by targeting claudin-2 protein degradation, " The Journal of Biological Chemistry, vol. 290, no. 11, pp. 7234-7246, 2015.
75. B. Willing, J. Halfvarson, J. Dicksved et al. , "Twin studies reveal specific imbalances in themucosa-Associated microbiota of patients with ileal Crohn's disease, " Inflammatory Bowel Diseases, vol. 15, no. 5, pp. 653-660, 2009.
76. A. Rehman, C. Sina, O. Gavrilova et al. , "Nod2 is essential for temporal development of intestinal microbial communities, " Gut, vol. 60, no. 10, pp. 1354-1362, 2011.
77. F. Fava and S. Danese, "Intestinal microbiota in inflammatory bowel disease: friend of foe?"World Journal of Gastroenterology, vol. 17, no. 5, pp. 557-566, 2011.
78. T. D. Martin, S. S. M. Chan, and A. R. Hart, "Environmental factors in the relapse and recurrence of inflammatory bowel disease: a review of the literature, " Digestive Diseases and Sciences, vol. 60, no. 5, pp. 1396-1405, 2015.
79. B. K. Rodino-Janeiro, C. Alonso-Cotoner, M. Pigrau, B. Lobo, M. Vicario, and J. Santos, "Role of corticotropin-releasing factor in gastrointestinal permeability, " Journal of Neurogastroenterology and Motility, vol. 21, no. 1, pp. 33-50, 2015.
80. J. Wyatt, H. Vogelsang, W. Hübl, T. Waldhöer, and H. Lochs, "Intestinal permeability and the prediction of relapse in Crohn's disease, " The Lancet, vol. 341, no. 8858, pp. 1437-1439, 1993.
81. R. D'Incà, V. Di Leo, D. Martines et al. , "Can permeability to sugars predict relapses in Crohn's disease?" Gut, vol. 34, no. 1, supplement, pp. S50-S73, 1993.
82. R. D'Incà, V. Di Leo, G. Corrao et al. , "Intestinal permeability test as a predictor of clinical course in Crohn's disease, " The American Journal of Gastroenterology, vol. 94, no. 10, pp. 2956-2960, 1999.
83. V. Di Leo, R. D'Incà, N. Diaz-Granado et al. , "Lactulose/mannitol test has high efficacy for excluding organic causes of chronic diarrhea, "The American Journal of Gastroenterology, vol. 98, no. 10, pp. 2245-2252, 2003.
84. R. Caccaro, R. D'Incà, M. Martinato et al. , "Fecal lactoferrin and intestinal permeability are effective non-invasivemarkers in the diagnostic work-up of chronic diarrhea, " BioMetals, vol. 27, no. 5, pp. 1069-1076, 2014.
85. S. O. Ukabam, J. R. Clamp, and B. T. Cooper, "Abnormal small intestinal permeability to sugars in patients with Crohn's disease of the terminal ileum and colon, " Digestion, vol. 27, no. 2, pp. 70-74, 1983.
86. F. Andre, C. Andre, Y. Emery, J. Forichon, L. Descos, and Y. Minaire, "Assessment of the lactulose-mannitol test in Crohn's disease, " Gut, vol. 29, no. 4, pp. 511-515, 1988.
87. J. Wyatt, G. Oberhuber, S. Pongratz et al. , "Increased gastric and intestinal permeability in patients with Crohn's disease, " American Journal of Gastroenterology, vol. 92, no. 10, pp. 1891-1896, 1997.
88. J. B. Meddings, L. R. Sutherland, N. I. Byles, and J. L. Wallace, "Sucrose: a novel permeability marker for gastroduodenal disease, " Gastroenterology, vol. 104, no. 6, pp. 1619-1626, 1993.
89. K. vanWijck, T. J. M. Verlinden, H. M. H. van Eijk et al. , "Novel multi-sugar assay for site-specific gastrointestinal permeability analysis: a randomized controlled crossover trial, " Clinical Nutrition, vol. 32, no. 2, pp. 245-251, 2013.
90. I. Bjarnason, C. O'Morain, A. J. Levi, and T. J. Peters, "Absorption of 51-chromium-label ethylenediaminoacetate in inflammatory bowel disease, " Gastroenterology, vol. 85, no. 2, pp. 318-322, 1983.
91. R. T. Jenkins, J. K. Ramage, D. B. Jones, S. M. Collins, R. L. Goodacre, andR. H. Hunt, "Small bowel and colonic permeability to 51Cr-EDTA in patients with active inflammatory bowel disease, " Clinical and Investigative Medicine, vol. 11, no. 2, pp. 151-155, 1988.
92. L. Pironi, M. Miglioli, E. Ruggeri et al. , "Relationship between intestinal permeability to [51Cr]EDTA and inflammatory activity in asymptomatic patients with Crohn's disease, " Digestive Diseases and Sciences, vol. 35, no. 5, pp. 582-588, 1990.
93. V. Becker, S. von Delius, M. Bajbouj, A. Karagianni, R. M. Schmid, and A. Meining, "Intravenous application of fluorescein for confocal laser scanning microscopy: evaluation of contrast dynamics and image quality with increasing injectionto-imaging time, " Gastrointestinal Endoscopy, vol. 68, no. 2, pp. 319-323, 2008.
94. M. I. Canto, S. Anandasabapathy, W. Brugge et al. , "In vivo endomicroscopy improves detection of Barrett's esophagusrelated neoplasia: a multicenter international randomized controlled trial (with video), " Gastrointestinal Endoscopy, vol. 79, no. 2, pp. 211-221, 2014.
95. G. H. Bok, S. R. Jeon, J. Y. Cho et al. , "The accuracy of probebased confocal endomicroscopy versus conventional endoscopic biopsies for the diagnosis of superficial gastric neoplasia (with videos), " Gastrointestinal Endoscopy, vol. 77, no. 6, pp. 899-908, 2013.
96. M. W. Shahid, A. M. Buchner, M. G. Heckmanet al. , "Diagnostic accuracy of probe-based confocal laser endomicroscopy and narrow band imaging for small colorectal polyps: a feasibility study, "The American Journal of Gastroenterology, vol. 107, no. 2, pp. 231-239, 2012.
97. M. W. Shahid, A. M. Buchner, E. Coron et al. , "Diagnostic accuracy of probe-based confocal laser endomicroscopy in detecting residual colorectal neoplasia after EMR: a prospective study, " Gastrointestinal Endoscopy, vol. 75, no. 3, pp. 525. e1-533. e1, 2012.
98. R. W. L. Leong, "Confocal endomicroscopy in the evaluation of celiac disease, " Endoscopy, vol. 42, no. 7, article 607, 2010.
99. A. Zambelli, V. Villanacci, E. Buscarini, G. Bassotti, and L. Albarello, "Collagenous colitis: a case series with confocal laser microscopy and histology correlation, " Endoscopy, vol. 40, no. 7, pp. 606-608, 2008.
100. A. Fritscher-Ravens, D. Schuppan, M. Ellrichmann et al. , "Confocal endomicroscopy shows food-Associated changes in the intestinal mucosa of patients with irritable bowel syndrome, " Gastroenterology, vol. 147, no. 5, pp. 1012-1020. e3, 2014.
101. R. Kiesslich, M. Goetz, E. M. Angus et al. , "Identification of epithelial gaps in human small and large intestine by confocal endomicroscopy, " Gastroenterology, vol. 133, no. 6, pp. 1769-1778, 2007.
102. J. J. Liu, K. L. Madsen, P. Boulanger, L. A. Dieleman, J. Meddings, and R. N. Fedorak, "Mind the gaps. Confocal endomicroscopy showed increased density of small bowel epithelial gaps in inflammatory bowel disease, " Journal of Clinical Gastroenterology, vol. 45, no. 3, pp. 240-245, 2011.
103. L. G. Lim, J. Neumann, T. Hansen et al. , "Confocal endomicroscopy identifies loss of local barrier function in the duodenum of patients with Crohn's disease and ulcerative colitis, " Inflammatory Bowel Diseases, vol. 20, no. 5, pp. 892-900, 2014.
104. R. Kiesslich, C. A. Duckworth, D. Moussata et al. , "Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease, " Gut, vol. 61, no. 8, pp. 1146-1153, 2012.
105. A. Buda, G. Hatem, H. Neumann et al. , "Confocal laser endomicroscopy for prediction of disease relapse in ulcerative colitis: a pilot study, " Journal of Crohn'sandColitis, vol. 8, no. 4, pp. 304-311, 2014.
106. P. Suenaert, V. Bulteel, S. Vermeire, M. Noman, G. Van Assche, and P. Rutgeerts, "Hyperresponsiveness of the mucosal barrier in Crohn's disease is not tumor necrosis factor-dependent, " Inflammatory Bowel Diseases, vol. 11, no. 7, pp. 667-673, 2005.
107. I. R. Sanderson, P. Boulton, I. Menzies, and J. A. Walker-Smith, "Improvement of abnormal lactulose/rhamnose permeability in active Crohn's disease of the small bowel by an elemental diet, " Gut, vol. 28, no. 9, pp. 1073-1076, 1987.
108. K. Teahon, P. Smethurst, M. Pearson, A. J. Levi, and I. Bjarnason, "The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease, " Gastroenterology, vol. 101, no. 1, pp. 84-89, 1991.
109. C. A. Chapman-Kiddell, P. S. W. Davies, L. Gillen, and G. L. Radford-Smith, "Role of diet in the development of inflammatory bowel disease, " Inflammatory Bowel Diseases, vol. 16, no. 1, pp. 137-151, 2010.
110. M. A. Hildebrandt, C. Hoffmann, S. A. Sherrill-Mix et al. , "High-fat diet determines the composition of the murine gut microbiome independently of obesity, " Gastroenterology, vol. 137, no. 5, pp. 1716. e2-1724. e2, 2009.
111. M. Serino, E. Luche, S. Gres et al. , "Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota, " Gut, vol. 61, no. 4, pp. 543-553, 2012.
112. M. Martinez-Medina, J. Denizot, N. Dreux et al. , "Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation, " Gut, vol. 63, no. 1, pp. 116-124, 2014.
113. A. Lerner and T. Matthias, "Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease, " Autoimmunity Reviews, vol. 14, no. 6, pp. 479-489, 2015.
114. M. E. Andrade, R. S. Araujo, P. A. V. de Barros et al. , "The role of immunomodulators on intestinal barrier homeostasis in experimental models, " Clinical Nutrition, 2015.
115. L. Pastorelli, C. D. Salvo, J. R. Mercado, M. Vecchi, and T. T. Pizarro, "Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: Lessons learned from animal models and human genetics, " Frontiers in Immunology, vol. 4, article 280, 2013.
116. I. A. Finnie, A. D. Dwarakanath, B. A. Taylor, and J. M. Rhodes, "Colonicmucin synthesis is increased by sodiumbutyrate, " Gut, vol. 36, no. 1, pp. 93-99, 1995.
117. A. Barcelo, J. Claustre, F. Moro, J.-A. Chayvialle, J.-C. Cuber, and P. Plaisancie, "Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon, " Gut, vol. 46, no. 2, pp. 218-224, 2000.
118. J. M. Mariadason, D. H. Barkla, and P. R. Gibson, "Effect of short-chain fatty acids on paracellular permeability in Caco-2 intestinal epithelium model, " American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 272, part 1, no. 4, pp. G705-G712, 1997.
119. L. Peng, Z. He, W. Chen, I. R. Holzman, and J. Lin, "Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier, " Pediatric Research, vol. 61, no. 1, pp. 37-41, 2007.
120. H. M. Hamer, D. Jonkers, K. Venema, S. Vanhoutvin, F. J. Troost, and R.-J. Brummer, "Review article: the role of butyrate on colonic function, " Alimentary Pharmacology & Therapeutics, vol. 27, no. 2, pp. 104-119, 2008.
121. S. Plöger, F. Stumpff, G. B. Penner et al. , "Microbial butyrate and its role for barrier function in the gastrointestinal tract, " Annals of the New York Academy of Sciences, vol. 1258, no. 1, pp. 52-59, 2012.
122. A. Venkatraman, B. S. Ramakrishna, A. B. Pulimood, S. Patra, and S. Murthy, "Increased permeability in dextran sulphate colitis in rats: time course of development and effect of butyrate, " Scandinavian Journal of Gastroenterology, vol. 35, no. 10, pp. 1053-1059, 2000.
123. P. Vernia, V. Annese, G. Bresci et al. , "Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial, " European Journal of Clinical Investigation, vol. 33, no. 3, pp. 244-248, 2003.
124. H. Lorenz-Meyer, P. Bauer, C. Nicolay et al. , "Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial, " Scandinavian Journal of Gastroenterology, vol. 31, no. 8, pp. 778-785, 1996.
125. W. Stremmel, U. Merle, A. Zahn, F. Autschbach, U. Hinz, and R. Ehehalt, "Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis, " Gut, vol. 54, no. 7, pp. 966-971, 2005.
126. W. Stremmel, R. Ehehalt, F. Autschbach, and M. Karner, "Phosphatidylcholine for steroid-refractory chronic ulcerative colitis: a randomized trial, " Annals of Internal Medicine, vol. 147, no. 9, pp. 603-610, 2007.
127. S. K. Roy, R. H. Behrens, R. Haider et al. , "Impact of zinc supplementation on intestinal permeability in Bangladeshi children with acute diarrhoea and persistent diarrhoea syndrome, " Journal of Pediatric Gastroenterology and Nutrition, vol. 15, no. 3, pp. 289-296, 1992.
128. A. N. Alam, S. A. Sarker, M. A. Wahed, M. Khatun, and M. M. Rahaman, "Enteric protein loss and intestinal permeability changes in children during acute shigellosis and after recovery: effect of zinc supplementation, " Gut, vol. 35, no. 12, pp. 1707-1711, 1994.
129. V. Di Leo, R. D'Incà, M. Barollo et al. , "Effect of zinc supplementation on trace elements and intestinal metallothionein concentrations in experimental colitis in the rat, " Digestive and Liver Disease, vol. 33, no. 2, pp. 135-139, 2001.
130. G. C. Sturniolo, V. Di Leo, A. Ferronato, A. D'Odorico, and R. D'Inc, "Zinc supplementation tightens 'leaky gut' in Crohn's disease, " Inflammatory Bowel Diseases, vol. 7, no. 2, pp. 94-98, 2001.
131. G. C. Sturniolo, W. Fries, E. Mazzon, V. Di Leo, M. Barollo, and R. D'Inca, "Effect of zinc supplementation on intestinal permeability in experimental colitis, " Journal of Laboratory and Clinical Medicine, vol. 139, no. 5, pp. 311-315, 2002.
132. W. Wang, L. Chen, R. Zhou et al. , "Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease, " Journal of ClinicalMicrobiology, vol. 52, no. 2, pp. 398-406, 2014.
133. D. Jonkers, J. Penders, A. Masclee, andM. Pierik, "Probiotics in the management of inflammatory bowel disease. A systematic review of intervention studies in adult patients, " Drugs, vol. 72, no. 6, pp. 803-823, 2012.
134. E. G. Vilela, M. D. L. D. A. Ferrari, H. O. D. G. Torres et al. , "Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission, " Scandinavian Journal of Gastroenterology, vol. 43, no. 7, pp. 842-848, 2008.
135. Z. Zakostelska, M. Kverka, K. Klimesova et al. , "Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment, " PLoS ONE, vol. 6, no. 11, Article ID e27961, 2011.
136. R. M. Patel, L. S. Myers, A. R. Kurundkar, A. Maheshwari, A. Nusrat, and P. W. Lin, "Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function, " American Journal of Pathology, vol. 180, no. 2, pp. 626-635, 2012.
137. S. N. Ukena, A. Singh, U. Dringenberg et al. , "Probiotic Escherichia coli nissle 1917 inhibits leaky gut by enhancing mucosal integrity, " PLoS ONE, vol. 2, no. 12, Article IDe1308, 2007.
138. M. Persborn, J. Gerritsen, C. Wallon, A. Carlsson, L. M. A. Akkermans, and J. D. Söderholm, "The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis, " Alimentary Pharmacology and Therapeutics, vol. 38, no. 7, pp. 772-783, 2013.
139. K. Machiels, M. Joossens, J. Sabino et al. , "A decrease of the butyrate-producing species roseburia hominis and faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis, " Gut, vol. 63, no. 8, pp. 1275-1283, 2014.
140. P. Marteau, "Butyrate-producing bacteria as pharmabiotics for inflammatory bowel disease, " Gut, vol. 62, no. 12, article 1673, 2013.
141. M. Moeinian, S. F. Ghasemi-Niri, S. Mozaffari et al. , "Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis, " World Journal of Gastroenterology, vol. 20, no. 31, pp. 10876-10885, 2014.
142. J. D. Simmons, C. Mullighan, K. I. Welsh, andD. P. Jewell, "Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility, " Gut, vol. 47, no. 2, pp. 211-214, 2000.
143. R. Dresner-Pollak, Z. Ackerman, R. Eliakim, A. Karban, Y. Chowers, and H. H. Fidder, "The BsmI vitamin D receptor gene polymorphism is associated with ulcerative colitis in Jewish Ashkenazi patients, " Genetic Testing, vol. 8, no. 4, pp. 417-420, 2004.
144. Y. C. Li, Y. Chen, and J. Du, "Critical roles of intestinal epithelial vitaminDreceptor signaling in controlling gutmucosal inflammation, " The Journal of Steroid Biochemistry and Molecular Biology, vol. 148, pp. 179-183, 2015.
145. S. Wu, Y.-G. Zhang, R. Lu et al. , "Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis, " Gut, vol. 64, no. 7, pp. 1082-1094, 2015.
146. M. O'Sullivan, "Vitamin D as a novel therapy in inflammatory bowel disease: new hope or false dawn?" Proceedings of the Nutrition Society, vol. 74, no. 1, pp. 5-12, 2015.